Association of HLA-C*03:02 with methimazole-induced liver injury in Graves’ disease patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Association of HLA-C*03:02 with methimazole-induced liver injury in Graves’ disease patients

Published:2019-09 Issue: Volume:117 Page:109095
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Li Xuesong,Jin Shasha,Fan Yujuan,Fan Xiaofang,Tang Zhijia,Cai Weimin,Yang Jialin,Xiang Xiaoqiang

Funder

Foundation of Shanghai Municipal Commission of Health and Family Planning

National Natural Science Foundation of China

Science and Technology Commission of Shanghai Municipality

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference50 articles.

1. Diagnosis and management of Graves disease: a global overview;Bartalena;Nat. Rev. Endocrinol.,2013

2. Graves’ disease;Smith;N. Engl. J. Med.,2016

3. Antithyroid drugs;Cooper;N. Engl. J. Med.,1984

4. 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis;Ross;Thyroid,2016

5. Methimazole-induced hepatotoxicity;Woeber;Endocr. Pract.,2002

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of drug-induced liver injury risk between propylthiouracil and methimazole: A quantitative systems toxicology approach;Toxicology and Applied Pharmacology;2024-10

2. Single-cell omics in tracing cellular heterogeneity of drug-induced liver injury: Technological landscape and prospective application;hLife;2024-07

3. Human Leucocyte Antigen Genetics in Idiosyncratic Drug-Induced Liver Injury with Evidence Based on the Roussel Uclaf Causality Assessment Method;Medicines;2024-04-11

4. The clinical application of genetic testing in DILI, are we there yet?;Clinical Liver Disease;2024-01

5. Review of human risk factors for idiosyncratic drug-induced liver injury: latest advances and future goals;Expert Opinion on Drug Metabolism & Toxicology;2023-11-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3